#Cannabis Capital Markets
#Cannabis Capital Markets · page 5
- CBD Market
Chinese CBD Market In The Sights Of Yooma After £6m EMMAC Deal
UK cannabis business EMMAC Life Sciences Group has sold its Yooma Wellness business for over $8m with the emerging Chinese wellness market in the sights of its new owners.
- Companies
Cannabis Shares Traded On The London Stock Exchange For First Time
CANNABIS shares will be traded for the first time in the 320-year history of the London Stock Exchange today – a milestone event for the UK and European industry.
- Pharmaceutical
World’s Largest Cannabis Deal Sees UK Firm GW Pharma Bought For $7.2bn
IRISH firm Jazz Pharmaceuticals has agreed to purchase UK medical cannabis trailblazer GW Pharmaceuticals for $7.2bn.
- Companies
Markets: UK CBD Firm’s Stock Price Up 1000% In 2020, Tilray & Aphria, EMMAC et al…
THIS time last year cannabis businesses were in the doldrums so the picture currently being viewed would have seemed a mirage back then.
- Pharmaceutical
Over 500 Deals Pitched To $200m UK Cannabis Fund
NEWLY-LAUNCHED legal medicinal cannabis fund Verdite Capital plans to make its first investments in the spring of 2021 – with team members having already considered over 500 deals in the sector.
- Pharmaceutical
New UK Cannabis Fund Closes In On Its First $75m Investment
ONE of the UK’s first cannabis investment funds is being backed by two of the industry’s global leaders as it closes in on its first $75m investment.
- Markets & Stocks
The Persevering Pair Who Helped Open The London Stock Exchange To Cannabis
PERSISTENCE has paid-off for an Israeli businessman and a UK lawyer after the London Stock Exchange issued its first ever listing guidelines for cannabis firms.
- Markets & Stocks
Will This Be The First Cannabis Company To List On The London Stock Exchange?
UK company Spinnaker Opportunities hopes to become the first cannabis company to list on the London Stock Exchange – within a matter of months.
- Pharmaceutical
UK Financial Regulator Outlines Route To Market For Cannabis Firms
EXPECT to see a significant uptick in market flotations of domestic and global medical cannabis companies after UK financial regulators outlined official listing guidelines for the first time.
- Events
Prohibition Partners Live Returns For Its Second Virtual Outing Of 2020
PROHIBITION Partners LIVE is back for its second outing this year with more than 1,500 delegates set to attend the virtual event.
- Companies
Market Round-Up; Branding Challenge – ‘What Gets Me High? Not ‘Who Makes It’. Organigram, Aurora, Lyphe Group et al
A THRIVING black market and cloying limits on sales and advertising are restricting cannabis brand recognition in the fast-growing Canadian legal market place.
